DekaBank Deutsche Girozentrale
VIR icon

DekaBank Deutsche Girozentrale’s Vir Biotechnology VIR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,100
Closed -$1.08M – 1529
2023
Q2 		$1.08M Hold
43,100
– – ﹤0.01% 861
2023
Q1 		$991K Hold
43,100
– – ﹤0.01% 869
2022
Q4 		$1.08M Hold
43,100
– – ﹤0.01% 855
2022
Q3 		$832K Hold
43,100
– – ﹤0.01% 918
2022
Q2 		$1.12M Hold
43,100
– – ﹤0.01% 853
2022
Q1 		$1.12M Buy
43,100
+3,900
+10% +$116K ﹤0.01% 895
2021
Q4 		$1.53M Buy
39,200
+1,100
+3% +$43.1K ﹤0.01% 835
2021
Q3 		$1.64M Hold
38,100
– – ﹤0.01% 769
2021
Q2 		$1.77M Hold
38,100
– – 0.01% 752
2021
Q1 		$1.82M Hold
38,100
– – 0.01% 724
2020
Q4 		$1.09M Buy
+38,100
New +$1.24M ﹤0.01% 847

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return